{"id":458,"date":"2024-05-30T11:30:00","date_gmt":"2024-05-30T02:30:00","guid":{"rendered":"https:\/\/asianicinsights.com\/?p=458"},"modified":"2024-06-30T01:27:20","modified_gmt":"2024-06-29T16:27:20","slug":"craft-health-a-leading-3d-printing-in-medicines-and-supplements-startup-raises-pre-series-a2-round","status":"publish","type":"post","link":"https:\/\/asianicinsights.com\/?p=458","title":{"rendered":"Craft Health, a leading 3D Printing in Medicines and Supplements Startup, raises Pre-Series A2 round."},"content":{"rendered":"<p>Craft Health Secures Pre-Series A2 Funding to Revolutionize Compounding Pharmacy with 3D Printing Technology.<\/p>\n<p>Singapore,13<br \/>\nMay 2024 \u2014 Craft Health, a pioneer in the healthcare industry specializing in<br \/>\nthe automation of mass customization through its cutting-edge 3D printing<br \/>\nplatform, today announced the successful close of its Pre-Series A2 funding<br \/>\nround. Valuence Ventures led the round with significant participation from<br \/>\nMistletoe Singapore, an existing investor, and an angel investor. This latest funding<br \/>\nunderscores the confidence investors have in Craft Health\u2019s vision to<br \/>\nrevolutionize compounding pharmacy on a global scale.<\/p>\n<p><img decoding=\"async\" style=\"width: 100%\" src=\"https:\/\/vritimes-public.s3.ap-southeast-1.amazonaws.com\/production\/393c561826cc2e418792e9aa86909fdb5e6ddac1123c89325c1134fc7192329e\/image.png\" alt=\"Image\" \/><\/p>\n<p>The fresh<br \/>\ncapital will expedite Craft Health\u2019s commercial trajectory by further<br \/>\ndeveloping its proprietary 3D printing platform designed to streamline and automate<br \/>\nthe mass customization of pharmaceuticals. By harnessing the power of its 3D<br \/>\nprinting platform, Craft Health aims to introduce unprecedented levels of<br \/>\nefficiency, precision, and customization to the compounding pharmacy sector,<br \/>\nmeeting the unique needs of patients with tailored medication solutions.<\/p>\n<p>\u201cWe<br \/>\nare delighted to bolster our investor base with partners who share our<br \/>\ndeep-tech vision and can impart their wealth of knowledge, experience, and<br \/>\nnetwork to scale Craft Health. This round of funding will fine-tune our commercialization<br \/>\nstrategy, refine our product offerings, and set the stage for our anticipated<br \/>\nSeries A\u201d said Dr Goh Wei Jiang, co-founder and CEO of Craft Health.<\/p>\n<p>&#8220;We<br \/>\nare thrilled to announce our investment in Craft Health, a pioneer in<br \/>\nleveraging 3D printing technology for compounding pharmacy. Craft Health&#8217;s<br \/>\ninnovative approach aligns perfectly with our mission to support ventures that<br \/>\nredefine industries and improve lives. We are confident in their potential to<br \/>\nrevolutionize personalized medicine and look forward to their continued growth<br \/>\nand success in transforming patient care globally.&#8221; said Dr. Gene Cho, a<br \/>\nGeneral Partner of Valuence Ventures. &#8220;Craft Health&#8217;s innovative use of 3D<br \/>\nprinting technology in compounding pharmacy not only positions the company at<br \/>\nthe forefront of healthcare innovation but also aligns perfectly with our<br \/>\ninvestment strategy of supporting ventures that are poised for significant<br \/>\nimpact and growth. We are confident in Craft Health&#8217;s vision and their ability<br \/>\nto lead a new era in personalized medicine, especially in the area of advanced<br \/>\nmaterials innovation.&#8221; <\/p>\n<p>Mistletoe<br \/>\nSingapore also expressed strong support for Craft Health&#8217;s mission and its<br \/>\nrecent funding success. &#8220;Having supported Craft Health from its early<br \/>\nstages, we have witnessed first-hand the dedication and innovation that the<br \/>\nteam brings to the healthcare industry. This additional funding will<br \/>\nundoubtedly propel the company towards achieving its commercial goals, and we<br \/>\nare excited to continue our journey with Craft Health as it endeavours to<br \/>\nrevolutionize the way pharmaceuticals are customized and dispensed.&#8221; Added<br \/>\nMr Atsushi Taira, Managing Director of Mistletoe Singapore.<\/p>\n<p>Since<br \/>\n2019, Craft Health has developed an end-to-end 3D printing platform for<br \/>\nnutraceuticals and pharmaceuticals, integrating the 3D printer (Craft<i>Make\u2122<\/i>),<br \/>\n3D printing software (Craft<i>Control\u2122<\/i>), 3D printable formulations (Craft<i>Blends\u2122<\/i>)<br \/>\nand one of the world\u2019s first semi-solid paste extrusion-based 3D printing<br \/>\ndatabase for oral dosage forms (Craft<i>Database\u2122<\/i>). Craft Health\u2019s<br \/>\ntechnology platform is based on the heat and ultraviolet light (UV) light free<br \/>\nsemi-solid paste extrusion technique and can incorporate a wide variety of<br \/>\nactive ingredients from small molecules to biological molecules. Craft Health<br \/>\nhas since commercialized its 3D printing platform, working with compounding<br \/>\npharmacies, academics, nutraceutical start-ups and MNCs.<\/p>\n<p>Craft<br \/>\nHealth&#8217;s commitment to innovation in healthcare through its 3D printing<br \/>\nplatform represents a significant leap forward in making personalized medicine<br \/>\nmore accessible and effective for patients worldwide. With this new round of<br \/>\nfunding, Craft Health is poised to make substantial advancements in the<br \/>\ncommercialization of its technology, setting a new standard for precision and<br \/>\npatient-centred care in the pharmaceutical industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Craft Health Secures Pre-Series A2 Funding to Revolutionize Compounding Pharmacy with 3D Printing Technology. Singapore,13 May 2024 \u2014 Craft Health, a pioneer in the healthcare industry specializing in the automation&hellip;<\/p>\n","protected":false},"author":1,"featured_media":460,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-singapore"],"_links":{"self":[{"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=458"}],"version-history":[{"count":1,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/458\/revisions"}],"predecessor-version":[{"id":459,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/posts\/458\/revisions\/459"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=\/wp\/v2\/media\/460"}],"wp:attachment":[{"href":"https:\/\/asianicinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asianicinsights.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}